Table 3. Description of ICU treatment frequencies for respondents in the six-month follow-up.
| ICU treatment | Yes |
|---|---|
| Sedation | 38.5% |
| Midazolam (benzodiazepine) | 19.2% |
| Propofol | 38.5% |
| Stress hormones | |
| Sympathomimetics pere op. | 31.4% |
| Parasympathomimetics pere op. | 5.9% |
| Sympathomimetics int. | 23.1% |
| Parasympath. Int. | 0% |
| Hydrocortisone (steroid) | 11.5% |
| LO coma | |
| Unconscious (spontaneously)a | 28.8% |
| Mean LO unconsciousness | |
| Hours | 0.16 (0.6, 0–4) |
| Days | 0.61 (2.3, 0–13) |
| Unconscious (by sedation) | 38.5% |
| Mean length of sedation (days) | 0.9 (2.4, 0–14.8) |
| Awakened during sedation | 9.6% |
| Tracheotomy | 5.8% |
| Fentanyl | 48.1% |
| Remifentanyl | 11.5% |
| Psychopharmacological drugs | 11.5% |
| Intensive delirium | 0% |
Note: ICU = Intensive Care Unit, LO = Length of.
aSome patients figure in both categories of unconsciousness.